These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 3006511

  • 1. Long-term effects of hypothalamic paraventricular lesion on CRF content and stimulated ACTH secretion.
    Makara GB, Stark E, Kapocs G, Antoni FA.
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E319-24. PubMed ID: 3006511
    [Abstract] [Full Text] [Related]

  • 2. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO, Plotsky PM, Vale WW.
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [Abstract] [Full Text] [Related]

  • 3. Effects of paraventricular lesions on stimulated ACTH release and CRF in stalk-median eminence of the rat.
    Makara GB, Stark E, Kárteszi M, Palkovits M, Rappay G.
    Am J Physiol; 1981 Apr; 240(4):E441-6. PubMed ID: 6261587
    [Abstract] [Full Text] [Related]

  • 4. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 5. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
    Walker CD, Tankosic P, Tilders FJ, Burlet A.
    J Neuroendocrinol; 1997 Jan; 9(1):25-41. PubMed ID: 9023736
    [Abstract] [Full Text] [Related]

  • 6. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D, Mergl Z, Makara GB.
    Brain Res; 2005 Jan 21; 1031(2):185-93. PubMed ID: 15649443
    [Abstract] [Full Text] [Related]

  • 7. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N, Oliver C, Grino M.
    J Neuroendocrinol; 2000 Aug 21; 12(8):774-83. PubMed ID: 10929090
    [Abstract] [Full Text] [Related]

  • 8. Corticosterone implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of corticotropin-releasing factor following neural stimuli.
    Feldman S, Saphier D, Weidenfeld J.
    Brain Res; 1992 Apr 24; 578(1-2):251-5. PubMed ID: 1324761
    [Abstract] [Full Text] [Related]

  • 9. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
    Ogilvie KM, Rivier C.
    Brain Res; 1997 Aug 22; 766(1-2):19-28. PubMed ID: 9359583
    [Abstract] [Full Text] [Related]

  • 10. The relative importance of hypothalamic neurons containing corticotropin-releasing factor or vasopressin in the regulation of adrenocorticotropic hormone secretion.
    Makara GB.
    Ciba Found Symp; 1992 Aug 22; 168():43-51; discussion 51-3. PubMed ID: 1330458
    [Abstract] [Full Text] [Related]

  • 11. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J, Grino M, Bernet F, Dutriez-Casteloot I, Montel V, Dupouy JP.
    J Neuroendocrinol; 1998 May 22; 10(5):331-42. PubMed ID: 9663647
    [Abstract] [Full Text] [Related]

  • 12. Chronic cold in adrenalectomized, corticosterone (B)-treated rats: facilitated corticotropin responses to acute restraint emerge as B increases.
    Akana SF, Dallman MF.
    Endocrinology; 1997 Aug 22; 138(8):3249-58. PubMed ID: 9231775
    [Abstract] [Full Text] [Related]

  • 13. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
    Stark E, Kárteszi M, Rappay G, Makara GB.
    J Endocrinol; 1981 Jan 22; 88(1):131-9. PubMed ID: 6257818
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of the hypothalamic-pituitary axis in adrenalectomised rats: potentiation by chronic stress.
    Martí O, Harbuz MS, Andrés R, Lightman SL, Armario A.
    Brain Res; 1999 Mar 06; 821(1):1-7. PubMed ID: 10064781
    [Abstract] [Full Text] [Related]

  • 16. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM, Sawchenko PE.
    Endocrinology; 1987 Apr 06; 120(4):1361-9. PubMed ID: 3030697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanisms by which stressful stimuli activate the pituitary-adrenal system.
    Makara GB.
    Fed Proc; 1985 Jan 06; 44(1 Pt 2):149-53. PubMed ID: 2981736
    [Abstract] [Full Text] [Related]

  • 19. Dopamine-beta-hydroxylase activity is necessary for hypothalamo-pituitary-adrenal (HPA) responses to ether, and stress-induced facilitation of subsequent HPA responses to acute ether emerges as HPA responses are inhibited by increasing corticosterone (B).
    Murakami K, Akana SF, Dallman MF.
    J Neuroendocrinol; 1997 Aug 06; 9(8):601-8. PubMed ID: 9283048
    [Abstract] [Full Text] [Related]

  • 20. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
    Dakine N, Oliver C, Grino M.
    Life Sci; 2000 Oct 27; 67(23):2827-44. PubMed ID: 11105998
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.